[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

United States T Cell Antigen Gp39 Market Report 2017

December 2017 | 99 pages | ID: UBB93C65509EN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the United States T Cell Antigen Gp39 market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
  • The West
  • Southwest
  • The Middle Atlantic
  • New England
  • The South
  • The Midwest
  • with sales (volume), revenue (value), market share and growth rate of T Cell Antigen Gp39 in these regions, from 2012 to 2022 (forecast).
United States T Cell Antigen Gp39 market competition by top manufacturers/players, with T Cell Antigen Gp39 sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Biogen, Inc.
  • Bristol-Myers Squibb Company
  • eTheRNA Immunotherapies NV
  • ImmuNext, Inc.
  • Juno Therapeutics Inc.
  • MedImmune, LLC
  • Targovax AS
  • XL-protein GmbH
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • ECI-006
  • Hepatitis B vaccine
  • INX-021
  • ISF-35
  • Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Graft Versus Host Disease
  • Breast Cancer
  • Bladder Cancer
  • Panceratic Cancer
  • Others
If you have any special requirements, please let us know and we will offer you the report as you want.
United States T Cell Antigen Gp39 Market Report 2017

1 T CELL ANTIGEN GP39 OVERVIEW

1.1 Product Overview and Scope of T Cell Antigen Gp39
1.2 Classification of T Cell Antigen Gp39 by Product Category
  1.2.1 United States T Cell Antigen Gp39 Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States T Cell Antigen Gp39 Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 ECI-006
  1.2.4 Hepatitis B vaccine
  1.2.5 INX-021
  1.2.6 ISF-35
  1.2.7 Others
1.3 United States T Cell Antigen Gp39 Market by Application/End Users
  1.3.1 United States T Cell Antigen Gp39 Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Graft Versus Host Disease
  1.3.3 Breast Cancer
  1.3.4 Bladder Cancer
  1.3.5 Panceratic Cancer
  1.3.6 Others
1.4 United States T Cell Antigen Gp39 Market by Region
  1.4.1 United States T Cell Antigen Gp39 Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West T Cell Antigen Gp39 Status and Prospect (2012-2022)
  1.4.3 Southwest T Cell Antigen Gp39 Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic T Cell Antigen Gp39 Status and Prospect (2012-2022)
  1.4.5 New England T Cell Antigen Gp39 Status and Prospect (2012-2022)
  1.4.6 The South T Cell Antigen Gp39 Status and Prospect (2012-2022)
  1.4.7 The Midwest T Cell Antigen Gp39 Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of T Cell Antigen Gp39 (2012-2022)
  1.5.1 United States T Cell Antigen Gp39 Sales and Growth Rate (2012-2022)
  1.5.2 United States T Cell Antigen Gp39 Revenue and Growth Rate (2012-2022)

2 UNITED STATES T CELL ANTIGEN GP39 MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States T Cell Antigen Gp39 Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States T Cell Antigen Gp39 Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States T Cell Antigen Gp39 Average Price by Players/Suppliers (2012-2017)
2.4 United States T Cell Antigen Gp39 Market Competitive Situation and Trends
  2.4.1 United States T Cell Antigen Gp39 Market Concentration Rate
  2.4.2 United States T Cell Antigen Gp39 Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers T Cell Antigen Gp39 Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES T CELL ANTIGEN GP39 SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States T Cell Antigen Gp39 Sales and Market Share by Region (2012-2017)
3.2 United States T Cell Antigen Gp39 Revenue and Market Share by Region (2012-2017)
3.3 United States T Cell Antigen Gp39 Price by Region (2012-2017)

4 UNITED STATES T CELL ANTIGEN GP39 SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States T Cell Antigen Gp39 Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States T Cell Antigen Gp39 Revenue and Market Share by Type (2012-2017)
4.3 United States T Cell Antigen Gp39 Price by Type (2012-2017)
4.4 United States T Cell Antigen Gp39 Sales Growth Rate by Type (2012-2017)

5 UNITED STATES T CELL ANTIGEN GP39 SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States T Cell Antigen Gp39 Sales and Market Share by Application (2012-2017)
5.2 United States T Cell Antigen Gp39 Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES T CELL ANTIGEN GP39 PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Biogen, Inc.
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 T Cell Antigen Gp39 Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Biogen, Inc. T Cell Antigen Gp39 Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Bristol-Myers Squibb Company
  6.2.2 T Cell Antigen Gp39 Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Bristol-Myers Squibb Company T Cell Antigen Gp39 Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 eTheRNA Immunotherapies NV
  6.3.2 T Cell Antigen Gp39 Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 eTheRNA Immunotherapies NV T Cell Antigen Gp39 Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 ImmuNext, Inc.
  6.4.2 T Cell Antigen Gp39 Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 ImmuNext, Inc. T Cell Antigen Gp39 Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Juno Therapeutics Inc.
  6.5.2 T Cell Antigen Gp39 Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Juno Therapeutics Inc. T Cell Antigen Gp39 Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 MedImmune, LLC
  6.6.2 T Cell Antigen Gp39 Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 MedImmune, LLC T Cell Antigen Gp39 Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Targovax AS
  6.7.2 T Cell Antigen Gp39 Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Targovax AS T Cell Antigen Gp39 Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 XL-protein GmbH
  6.8.2 T Cell Antigen Gp39 Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 XL-protein GmbH T Cell Antigen Gp39 Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview

7 T CELL ANTIGEN GP39 MANUFACTURING COST ANALYSIS

7.1 T Cell Antigen Gp39 Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of T Cell Antigen Gp39

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 T Cell Antigen Gp39 Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of T Cell Antigen Gp39 Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES T CELL ANTIGEN GP39 MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States T Cell Antigen Gp39 Sales Volume, Revenue Forecast (2017-2022)
11.2 United States T Cell Antigen Gp39 Sales Volume Forecast by Type (2017-2022)
11.3 United States T Cell Antigen Gp39 Sales Volume Forecast by Application (2017-2022)
11.4 United States T Cell Antigen Gp39 Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of T Cell Antigen Gp39
Figure United States T Cell Antigen Gp39 Market Size (K Pcs) by Type (2012-2022)
Figure United States T Cell Antigen Gp39 Sales Volume Market Share by Type (Product Category) in 2016
Figure ECI-006 Product Picture
Figure Hepatitis B vaccine Product Picture
Figure INX-021 Product Picture
Figure ISF-35 Product Picture
Figure Others Product Picture
Figure United States T Cell Antigen Gp39 Market Size (K Pcs) by Application (2012-2022)
Figure United States Sales Market Share of T Cell Antigen Gp39 by Application in 2016
Figure Graft Versus Host Disease Examples
Table Key Downstream Customer in Graft Versus Host Disease
Figure Breast Cancer Examples
Table Key Downstream Customer in Breast Cancer
Figure Bladder Cancer Examples
Table Key Downstream Customer in Bladder Cancer
Figure Panceratic Cancer Examples
Table Key Downstream Customer in Panceratic Cancer
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States T Cell Antigen Gp39 Market Size (Million USD) by Region (2012-2022)
Figure The West T Cell Antigen Gp39 Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest T Cell Antigen Gp39 Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic T Cell Antigen Gp39 Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England T Cell Antigen Gp39 Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US T Cell Antigen Gp39 Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest T Cell Antigen Gp39 Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States T Cell Antigen Gp39 Sales (K Pcs) and Growth Rate (2012-2022)
Figure United States T Cell Antigen Gp39 Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States T Cell Antigen Gp39 Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table United States T Cell Antigen Gp39 Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table United States T Cell Antigen Gp39 Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States T Cell Antigen Gp39 Sales Share by Players/Suppliers
Figure 2017 United States T Cell Antigen Gp39 Sales Share by Players/Suppliers
Figure United States T Cell Antigen Gp39 Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States T Cell Antigen Gp39 Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States T Cell Antigen Gp39 Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States T Cell Antigen Gp39 Revenue Share by Players/Suppliers
Figure 2017 United States T Cell Antigen Gp39 Revenue Share by Players/Suppliers
Table United States Market T Cell Antigen Gp39 Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)
Figure United States Market T Cell Antigen Gp39 Average Price (USD/Pcs) of Key Players/Suppliers in 2016
Figure United States T Cell Antigen Gp39 Market Share of Top 3 Players/Suppliers
Figure United States T Cell Antigen Gp39 Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers T Cell Antigen Gp39 Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers T Cell Antigen Gp39 Product Category
Table United States T Cell Antigen Gp39 Sales (K Pcs) by Region (2012-2017)
Table United States T Cell Antigen Gp39 Sales Share by Region (2012-2017)
Figure United States T Cell Antigen Gp39 Sales Share by Region (2012-2017)
Figure United States T Cell Antigen Gp39 Sales Market Share by Region in 2016
Table United States T Cell Antigen Gp39 Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States T Cell Antigen Gp39 Revenue Share by Region (2012-2017)
Figure United States T Cell Antigen Gp39 Revenue Market Share by Region (2012-2017)
Figure United States T Cell Antigen Gp39 Revenue Market Share by Region in 2016
Table United States T Cell Antigen Gp39 Price (USD/Pcs) by Region (2012-2017)
Table United States T Cell Antigen Gp39 Sales (K Pcs) by Type (2012-2017)
Table United States T Cell Antigen Gp39 Sales Share by Type (2012-2017)
Figure United States T Cell Antigen Gp39 Sales Share by Type (2012-2017)
Figure United States T Cell Antigen Gp39 Sales Market Share by Type in 2016
Table United States T Cell Antigen Gp39 Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States T Cell Antigen Gp39 Revenue Share by Type (2012-2017)
Figure Revenue Market Share of T Cell Antigen Gp39 by Type (2012-2017)
Figure Revenue Market Share of T Cell Antigen Gp39 by Type in 2016
Table United States T Cell Antigen Gp39 Price (USD/Pcs) by Types (2012-2017)
Figure United States T Cell Antigen Gp39 Sales Growth Rate by Type (2012-2017)
Table United States T Cell Antigen Gp39 Sales (K Pcs) by Application (2012-2017)
Table United States T Cell Antigen Gp39 Sales Market Share by Application (2012-2017)
Figure United States T Cell Antigen Gp39 Sales Market Share by Application (2012-2017)
Figure United States T Cell Antigen Gp39 Sales Market Share by Application in 2016
Table United States T Cell Antigen Gp39 Sales Growth Rate by Application (2012-2017)
Figure United States T Cell Antigen Gp39 Sales Growth Rate by Application (2012-2017)
Table Biogen, Inc. Basic Information List
Table Biogen, Inc. T Cell Antigen Gp39 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Biogen, Inc. T Cell Antigen Gp39 Sales Growth Rate (2012-2017)
Figure Biogen, Inc. T Cell Antigen Gp39 Sales Market Share in United States (2012-2017)
Figure Biogen, Inc. T Cell Antigen Gp39 Revenue Market Share in United States (2012-2017)
Table Bristol-Myers Squibb Company Basic Information List
Table Bristol-Myers Squibb Company T Cell Antigen Gp39 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb Company T Cell Antigen Gp39 Sales Growth Rate (2012-2017)
Figure Bristol-Myers Squibb Company T Cell Antigen Gp39 Sales Market Share in United States (2012-2017)
Figure Bristol-Myers Squibb Company T Cell Antigen Gp39 Revenue Market Share in United States (2012-2017)
Table eTheRNA Immunotherapies NV Basic Information List
Table eTheRNA Immunotherapies NV T Cell Antigen Gp39 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure eTheRNA Immunotherapies NV T Cell Antigen Gp39 Sales Growth Rate (2012-2017)
Figure eTheRNA Immunotherapies NV T Cell Antigen Gp39 Sales Market Share in United States (2012-2017)
Figure eTheRNA Immunotherapies NV T Cell Antigen Gp39 Revenue Market Share in United States (2012-2017)
Table ImmuNext, Inc. Basic Information List
Table ImmuNext, Inc. T Cell Antigen Gp39 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure ImmuNext, Inc. T Cell Antigen Gp39 Sales Growth Rate (2012-2017)
Figure ImmuNext, Inc. T Cell Antigen Gp39 Sales Market Share in United States (2012-2017)
Figure ImmuNext, Inc. T Cell Antigen Gp39 Revenue Market Share in United States (2012-2017)
Table Juno Therapeutics Inc. Basic Information List
Table Juno Therapeutics Inc. T Cell Antigen Gp39 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Juno Therapeutics Inc. T Cell Antigen Gp39 Sales Growth Rate (2012-2017)
Figure Juno Therapeutics Inc. T Cell Antigen Gp39 Sales Market Share in United States (2012-2017)
Figure Juno Therapeutics Inc. T Cell Antigen Gp39 Revenue Market Share in United States (2012-2017)
Table MedImmune, LLC Basic Information List
Table MedImmune, LLC T Cell Antigen Gp39 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure MedImmune, LLC T Cell Antigen Gp39 Sales Growth Rate (2012-2017)
Figure MedImmune, LLC T Cell Antigen Gp39 Sales Market Share in United States (2012-2017)
Figure MedImmune, LLC T Cell Antigen Gp39 Revenue Market Share in United States (2012-2017)
Table Targovax AS Basic Information List
Table Targovax AS T Cell Antigen Gp39 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Targovax AS T Cell Antigen Gp39 Sales Growth Rate (2012-2017)
Figure Targovax AS T Cell Antigen Gp39 Sales Market Share in United States (2012-2017)
Figure Targovax AS T Cell Antigen Gp39 Revenue Market Share in United States (2012-2017)
Table XL-protein GmbH Basic Information List
Table XL-protein GmbH T Cell Antigen Gp39 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure XL-protein GmbH T Cell Antigen Gp39 Sales Growth Rate (2012-2017)
Figure XL-protein GmbH T Cell Antigen Gp39 Sales Market Share in United States (2012-2017)
Figure XL-protein GmbH T Cell Antigen Gp39 Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of T Cell Antigen Gp39
Figure Manufacturing Process Analysis of T Cell Antigen Gp39
Figure T Cell Antigen Gp39 Industrial Chain Analysis
Table Raw Materials Sources of T Cell Antigen Gp39 Major Players/Suppliers in 2016
Table Major Buyers of T Cell Antigen Gp39
Table Distributors/Traders List
Figure United States T Cell Antigen Gp39 Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States T Cell Antigen Gp39 Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States T Cell Antigen Gp39 Price (USD/Pcs) Trend Forecast (2017-2022)
Table United States T Cell Antigen Gp39 Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States T Cell Antigen Gp39 Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States T Cell Antigen Gp39 Sales Volume (K Pcs) Forecast by Type in 2022
Table United States T Cell Antigen Gp39 Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States T Cell Antigen Gp39 Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States T Cell Antigen Gp39 Sales Volume (K Pcs) Forecast by Application in 2022
Table United States T Cell Antigen Gp39 Sales Volume (K Pcs) Forecast by Region (2017-2022)
Table United States T Cell Antigen Gp39 Sales Volume Share Forecast by Region (2017-2022)
Figure United States T Cell Antigen Gp39 Sales Volume Share Forecast by Region (2017-2022)
Figure United States T Cell Antigen Gp39 Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories